These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 7385708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cellular immunity in breast cancer patients].
    Spielmann M, Kitschke HJ, Tietje K.
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [Abstract] [Full Text] [Related]

  • 6. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ, Tarpley JL, Potvin C, Chretien PB.
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cellular immunity indices in primary cancer and nontumorous diseases of the liver].
    Komissarenko VG, Shaĭn AA.
    Vopr Onkol; 1981 Feb; 27(1):36-40. PubMed ID: 6969949
    [Abstract] [Full Text] [Related]

  • 10. Phytohemagglutinin (PHA) skin test. Characterization of immunological properties and clinical application.
    Nishido T.
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):43-55. PubMed ID: 371848
    [Abstract] [Full Text] [Related]

  • 11. [State of immunological reactivity in breast cancer patients receiving prednisolone treatment].
    Tsyrlina EV, Fedorov SN, Poroshina TE, Buslaeva VP, Seleznev IK.
    Vopr Onkol; 1979 Mar; 25(5):60-2. PubMed ID: 462856
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Improvement of the indicators of cellular immunity under the effect of polypeptide epiphyseal extract (epithalamine)].
    Dil'man VM.
    Vopr Onkol; 1977 Mar; 23(6):7-9. PubMed ID: 303411
    [Abstract] [Full Text] [Related]

  • 15. [Immune reactions in assessing the disease prognosis in soft tissue sarcomas].
    Klimenkov AA, Kadagidze ZG, Gladikov IuV.
    Vopr Onkol; 1979 Mar; 25(1):3-8. PubMed ID: 425395
    [Abstract] [Full Text] [Related]

  • 16. [Cellular immunity in myasthenia gravis].
    Mendes N, Kopersztych S, Saraiva S, de Assis JL.
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Dec; 33(6):272-6. PubMed ID: 311506
    [No Abstract] [Full Text] [Related]

  • 17. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
    Lipenský R, Urban K.
    Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
    [No Abstract] [Full Text] [Related]

  • 18. [Features of cellular immunity of chronic lympholeukemia].
    Sinitsina AM, Zverkova AS.
    Vrach Delo; 1982 Dec; (10):49-51. PubMed ID: 6983781
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of the immunological reactivity and hormonal profile in patients with breast cancer].
    Baisheva SA, Bogdanova AG.
    Vopr Onkol; 1984 Dec; 30(12):19-23. PubMed ID: 6516268
    [Abstract] [Full Text] [Related]

  • 20. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S, Haftek M, Sliński W.
    Dermatologica; 1977 Dec; 155(1):13-25. PubMed ID: 303184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.